Research and development and clinical effect evaluation of antiSARS-CoV-2 new nucleoside drugs
- Funded by BRICS
- Total publications:0 publications
Grant number: 071 - RDCEEA-SC-2NND
Grant search
Key facts
Disease
COVID-19Funder
BRICSPrincipal Investigator
Renato Martins da Silva, Mariia Sergeeva, Jijie ChaiResearch Location
Brazil, RussiaLead Research Institution
Galzu Institute for Research, Research Institute of Influenza, Tsinghua UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable